| Profile | GDS1873 / 213057_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 275.544 | 63 |
| GSM40788 | control - Rep 2 | 246.344 | 60 |
| GSM40789 | control - Rep 3 | 266.277 | 62 |
| GSM40775 | androgen treated - Rep 1 | 203.628 | 54 |
| GSM40776 | androgen treated - Rep 2 | 286.978 | 64 |
| GSM40777 | androgen treated - Rep 3 | 234.74 | 58 |
| GSM40790 | estrogen treated - Rep 1 | 237.793 | 59 |
| GSM40791 | estrogen treated - Rep 2 | 214.095 | 56 |
| GSM40792 | estrogen treated - Rep 3 | 282.358 | 63 |
| GSM40784 | A + tamoxifen - Rep 1 | 227.025 | 58 |
| GSM40785 | A + tamoxifen - Rep 2 | 256.855 | 61 |
| GSM40786 | A + tamoxifen - Rep 3 | 238.17 | 59 |
| GSM40778 | A + anastrozole - Rep 1 | 241.785 | 59 |
| GSM40779 | A + anastrozole - Rep 2 | 243.309 | 59 |
| GSM40780 | A + anastrozole - Rep 3 | 307.664 | 66 |
| GSM40781 | A + letrozole - Rep 1 | 250.47 | 60 |
| GSM40782 | A + letrozole - Rep 2 | 269.29 | 62 |
| GSM40783 | A + letrozole - Rep 3 | 333.649 | 68 |